论文部分内容阅读
目的:分析对宫颈感染高危型HPV病毒的患者实施保妇康栓联合干扰素治疗的临床疗效。方法:将我院收治的100例宫颈感染高危型HPV病毒患者进行随机分组,即对照组和观察组,均50例。分别对其实施干扰素治疗和在此基础上的保妇康栓治疗,比较治疗效果。结果:两组患者均有一定效果,但相比对照组,观察组的治疗有效率明显更高,差异有统计学意义(P<0.05)。结论:在对宫颈感染HPV病毒患者治疗时,使用保妇康栓联合干扰素的方法治疗可明显提升治疗效果,有较高的临床应用价值。
Objective: To analyze the clinical efficacy of Baofukang Suppository combined with interferon in patients with cervical HPV infection. Methods: 100 cases of high risk HPV infection in our hospital were randomly divided into control group and observation group, all of which were 50 cases. Respectively to its implementation of interferon treatment and on this basis Baofukang suppository treatment, the treatment effect. Results: The two groups of patients had some effect, but the treatment group was significantly higher than the control group, the difference was statistically significant (P <0.05). Conclusion: In the treatment of patients with cervical HPV infection, the use of Baofukang suppository combined with interferon treatment can significantly improve the treatment effect, a higher clinical value.